Quick Heal Technologies Limited (QUICKHEAL) — Financial Results

· NSE 🔴 High Importance Neutral

Investor Takeaways

  • Revenue declined to ₹70.61 Cr in Q3FY25 from ₹80.03 Cr in Q4FY24, though profit remained positive at ₹0.11 Cr.
  • Q3FY25 recorded negative operating profit margin (OPM) of -5.34%, contrasting sharply with ₹14.04 Cr profit and 12.55% OPM in Q4FY24.
  • EPS fell to ₹0.02 in Q3FY25 from ₹2.63 in Q4FY24, indicating significant quarterly volatility.
  • ⚠️ No specific risks or concerns were mentioned in the filing.
  • Overall Tone: Cautious based on the numbers only.

    Key Financial Highlights

    MetricValueYoY Change
    Revenue₹70.61 Cr-11.7% (Q3FY25 vs Q4FY24)
    Net Profit₹0.11 Cr-99.2% (Q3FY25 vs Q4FY24)
    EBITDANot availableN/A
    EPS₹0.02-99.2% (Q3FY25 vs Q4FY24)
    OPM-5.34%-1789 basis points (Q3FY25 vs Q4FY24)

    What Changed

    The company's financial performance showed a sharp deterioration in Q3FY25 compared to the previous quarter (Q4FY24). Revenue declined by 11.7% to ₹70.61 Cr, while net profit plummeted by 99.2% to ₹0.11 Cr. This resulted in a negative operating profit margin of -5.34%, a stark reversal from the 12.55% OPM and ₹14.04 Cr profit recorded in Q4FY24. Earnings per share (EPS) also dropped dramatically to ₹0.02 from ₹2.63, reflecting severe quarterly weakness. The filing only released the transcript of an investor call held on May 22, 2026, without disclosing new financial results or operational updates. No forward-looking guidance or strategic initiatives were detailed in the provided data. The company’s current market capitalization stands at ₹1,131.12 Cr with a P/E ratio of 50, which is significantly higher than sector peers.

    Peer Comparison

    CompanyP/EROEROCEMarket Cap (₹ Cr)
    Quick Heal Technologies Limited50Not availableNot available1,131.12
    Tata Consultancy Services Limited (TCS)17.1750.36%67.57%8,19,135.01
    Infosys Limited (INFY)16.5529.19%40.82%4,53,824.26
    HCL Technologies Limited (HCLTECH)18.6423.63%31.85%3,07,349.71

    Quick Heal’s P/E ratio of 50 is substantially higher than TCS (17.17), Infosys (16.55), and HCL Technologies (18.64), suggesting market expectations may be priced at a premium despite weaker recent financials.

    Risks & Concerns

  • No specific risks or concerns were identified in the filing.
  • The sharp decline in profitability and negative OPM in Q3FY25 represent material operational headwinds, though not explicitly labeled as risks in the provided text.
  • 📄 View Original Announcement (PDF)

    About Quick Heal Technologies Limited (QUICKHEAL)

    Information Technology · IT - Software · Listed on NSE

    Market Cap: ₹1,131.12 Cr P/E: 50.0

    View full QUICKHEAL stock details →

    📡 Get AI alerts when QUICKHEAL files next

    Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

    Track QUICKHEAL — Free

    📊 More QUICKHEAL filings

    See all QUICKHEAL filings →

    Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

    📡 Get AI alerts when QUICKHEAL files new disclosures

    Track QUICKHEAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

    Track QUICKHEAL — Free

    Free account · 2 AI queries/day